Association between inflammation and skeletal muscle proteolysis, skeletal mass and strength in elderly heart failure patients and their prognostic implications

被引:41
作者
Koshikawa, Masayuki [1 ]
Harada, Masahide [1 ]
Noyama, Shunsuke [2 ]
Kiyono, Ken [2 ]
Motoike, Yuji [1 ]
Nomura, Yoshihiro [1 ]
Nishimura, Asuka [1 ]
Izawa, Hideo [3 ]
Watanabe, Eiichi [1 ]
Ozaki, Yukio [1 ]
机构
[1] Fujita Hlth Univ, Sch Med, Dept Cardiol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan
[2] Osaka Univ, Div Bioengn, Grad Sch Engn Sci, Toyonaka, Osaka, Japan
[3] Fujita Hlth Univ, Sch Med, Bantane Hosp, Dept Cardiol, Nagoya, Aichi, Japan
关键词
Elderly; Sarcopenia; Frailty; Mortality; C-REACTIVE PROTEIN; N-TAU-METHYLHISTIDINE; URINARY-EXCRETION; IN-VIVO; 3-METHYLHISTIDINE; SARCOPENIA; ATROPHY; RATES; ACID;
D O I
10.1186/s12872-020-01514-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Inflammation and skeletal muscle wasting often coexist in elderly populations, but few studies have examined their relationship in elderly heart failure (HF) patients. This study examined the relationship between inflammation and increased skeletal muscle proteolysis, reduced skeletal mass and strength, and their prognostic implications in elderly HF patients (> 65 years) using a random forest approach. Methods We prospectively enrolled consecutive elderly HF patients (n = 78) and age- and sex-matched control subjects (n = 83). We measured the interleukin (IL)-6, C-reactive protein (CRP), and B-type natriuretic peptide (BNP) levels, lower limb muscle mass and strength, and 6-min walk distance. The amount of muscle proteolysis was determined by urinary 3-methylhystidine, normalized by creatinine (3-MH/Cr). The composite endpoint was defined as all-cause death or hospitalizations due to worsening HF. Results Compared to controls, elderly HF patients had a significantly higher IL-6, CRP, BNP, and 3-MH/Cr, and exhibited a reduced lower limb muscle mass and strength. A correlation analysis demonstrated significant positive correlations between the inflammatory cytokine levels and 3-MH/Cr and BNP, and negative correlations with the lower limb muscle mass and strength, and 6-min walk distance. During a median follow-up of 2.4-years, 24 patients reached the endpoint. A random forest model revealed that inflammatory cytokines, skeletal muscle wasting, and the BNP had greater effects on the risk prediction. The algorithm achieved an area under the receiver operating characteristic curve of 0.887 (95% CI, 0.772-1.000). Conclusion This study provided evidence of the association between inflammation and increased skeletal muscle proteolysis, reduced skeletal mass and strength, and their prognostic roles in elderly HF patients.
引用
收藏
页数:9
相关论文
共 36 条
[1]   C-reactive protein in heart failure - Prognostic value and the effect of valsartan [J].
Anand, IS ;
Latini, R ;
Florea, VG ;
Kuskowski, MA ;
Rector, T ;
Masson, S ;
Signorini, S ;
Mocarelli, P ;
Hester, A ;
Glazer, R ;
Cohn, JN .
CIRCULATION, 2005, 112 (10) :1428-1434
[2]   3-METHYLHISTIDINE A COMPONENT OF ACTIN [J].
ASATOOR, AM ;
ARMSTRONG, MD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1967, 26 (02) :168-+
[3]   PLASMA-LEVELS OF 3-METHYLHISTIDINE AFTER INGESTION OF THE PURE AMINO-ACID OR OF MUSCULAR PROTEINS MEASURED BY RADIOIMMUNOASSAY [J].
BACHMANN, K ;
GALEAZZI, R ;
MILLET, A ;
BURGER, AG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1984, 33 (02) :107-110
[4]   MUSCLE PROTEIN BREAKDOWN RATES IN HUMANS BASED ON NTAU-METHYLHISTIDINE (3-METHYLHISTIDINE) CONTENT OF MIXED PROTEINS IN SKELETAL-MUSCLE AND URINARY OUTPUT OF NTAU-METHYLHISTIDINE [J].
BILMAZES, C ;
UAUY, R ;
HAVERBERG, LN ;
MUNRO, HN ;
YOUNG, VR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1978, 27 (05) :525-530
[5]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[6]   Alterations in the in vitro and in vivo regulation of muscle regeneration in healthy ageing and the influence of sarcopenia [J].
Brzeszczynska, Joanna ;
Meyer, Angelika ;
McGregor, Robin ;
Schilb, Alain ;
Degen, Simone ;
Tadini, Valentina ;
Johns, Neil ;
Langen, Ramon ;
Schols, Annemie ;
Glass, David J. ;
Roubenoff, Ronenn ;
Ross, James A. ;
Fearon, Kenneth C. H. ;
Greig, Carolyn A. ;
Jacobi, Carsten .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2018, 9 (01) :93-105
[7]   Methods for measuring tissue protein breakdown rate in vivo [J].
Chinkes, DL .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (05) :534-537
[8]   Size and strength of the respiratory and quadriceps muscles in patients with chronic asthma [J].
deBruin, PF ;
Ueki, J ;
Watson, A ;
Pride, NB .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (01) :59-64
[9]  
Deswal A, 2001, CIRCULATION, V103, P2055
[10]   Loss of muscle mass: Current developments in cachexia and sarcopenia focused on biomarkers and treatment [J].
Drescher, Cathleen ;
Konishi, Masaaki ;
Ebner, Nicole ;
Springer, Jochen .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 :766-772